SBGI heads into the summer with a striking split signal: short sellers are rebuilding positions at the fastest pace in months, while the company's own Executive Chairman spent $26 million buying shares at almost exactly the same price the stock trades at today.
The insider angle is the headline. David Smith's acquisition of 2 million shares on March 27 at $13.14 each — totalling roughly $26.3 million across multiple tranches — remains the defining event of the past 90 days. Net insider buying over that period reached 4.6 million shares worth $62 million, an unusually large cluster for a broadcaster of this size. The contrast with director-level selling is stark: two directors offloaded a combined ~73,000 shares in March and May, pocket change relative to Smith's commitment. At $13.76, the stock trades only fractionally above his acquisition price, meaning Smith is currently sitting on a thin paper gain. The signal is unusual enough to demand attention regardless of one's broader view on the name.
Short interest tells a less comfortable story. Bears have been adding aggressively — SI has climbed 10.3% in a week and nearly 14% over the past month, reaching 8.6% of the free float. That's a meaningful position. The pace of the rebuild is worth noting: from early June, short shares jumped from roughly 3.58 million to nearly 3.95 million in less than two weeks, the sharpest sustained increase since May. The ORTEX short score ticked up to 60.2 on Tuesday, a level not seen for this name since the jump registered on June 8. Despite the growing short book, the borrow market remains undemanding. Availability is ample — nearly seven shares available for every one currently borrowed — and the cost to borrow at 0.43% is close to the lowest of the year, a long way from the brief spike above 2% in early May. Availability has tightened week-on-week from roughly 760% to 680%, but that still falls comfortably within normal ranges. Short positioning is growing, but not yet facing any squeeze pressure.
Options positioning is mildly defensive without being extreme. The put/call ratio at 1.12 is slightly below its 20-day average of 1.17, a modest normalisation after weeks of heavier protection-buying. The 52-week PCR range runs from 0.20 to 1.34, so the current reading places options traders in the cautious-but-not-panicked zone. The shift mirrors the price action: SBGI is down 2.3% on the week to $13.76, giving back the prior session's 2.5% bounce, in a week when closest peer GTN fell 4.2% and NXST dropped 4.2% on similar advertising headwinds. SSP fared worse, off nearly 15%.
The Street's view remains split, with the most recent analyst actions from May all pointing the same direction: lower targets, held ratings. Guggenheim trimmed to $19 and kept Buy; Wells Fargo cut to $16 at Equal-Weight; JP Morgan shaved to $14 at Underweight. The consensus mean target is $17.71, implying roughly 29% upside from current levels — though the spread between the $14 Underweight target and the $19 Buy target captures the debate precisely. Bulls point to Sinclair's 185-station footprint reaching 40% of US households and potential strategic actions including separations or partnerships. Bears flag secular advertising declines, cord-cutting, subscriber attrition, and the refinancing risk that sits behind an EV/EBITDA multiple of 7.5x on a company carrying meaningful leverage. The dividend score ranks in the 98th percentile of the universe, but the last actual dividend payment was in 2022 — the high score likely reflects historical data and should not be taken as a forward indicator. The EP and PE multiples are both negative, reflecting losses at the bottom line.
With the next earnings event scheduled for August 5, the period ahead offers time for the Smith-versus-shorts tension to play out. The key question is whether Smith's $13-handle conviction buying proves a floor for the stock, or whether the accelerating short rebuild signals something the Executive Chairman's buy order has not yet resolved.
See the live data behind this article on ORTEX.
Open SBGI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
